Disc Medicine IRON Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $45.9M-0.7% | $46.22M-8.2% | $50.33M+8.7% | $46.32M+66.8% | $27.76M+12.0% | ||
| $23.62M+13.9% | $20.75M+19.5% | $17.36M+15.0% | $15.09M+23.9% | $12.18M+24.9% | ||
| $69.52M+3.8% | $66.97M-1.1% | $67.7M+10.2% | $61.41M+53.7% | $39.95M+15.6% | ||
| $844K-4.4% | $883K-3.7% | $917K+0.8% | $910K+1.4% | $897K+56.8% | ||
| $6.07M-7.0% | $6.53M+19.2% | $5.48M-11.9% | $6.22M+3.9% | $5.98M+13.5% | ||
| $51K-42.0% | $88K-13.7% | $102K+96.2% | $52K-56.3% | $119K-32.4% | ||
| -$63.5M-4.9% | -$60.53M+2.9% | -$62.32M-12.8% | -$55.25M-62.1% | -$34.09M-15.7% | ||
| -$1.65-1.9% | -$1.62+8.5% | -$1.77-12.0% | -$1.58-54.9% | -$1.02-4.1% | ||
| -$69.44M-3.8% | -$66.88M+1.1% | -$67.61M-10.2% | -$61.33M-53.6% | -$39.93M-15.6% | ||
| -$69.52M-3.8% | -$66.97M+1.1% | -$67.7M-10.2% | -$61.41M-53.7% | -$39.95M-15.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Disc Medicine profitable?
- Disc Medicine is not currently profitable: it reported a net loss of $241.6M over the trailing twelve months.
- What is Disc Medicine's earnings per share?
- Disc Medicine's diluted EPS over the trailing twelve months is $-6.62.
- Where does Disc Medicine's income statement data come from?
- Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.